Steven Stanowicz
Dermatology · Orange, CANPI 1649204520
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novartis at 27.8% of the total. Reporting peaked in 2019 at $822 and has fallen 86.9% since, to $107 in 2025.
Across 111 payments — averaging $20.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$647
- AbbVie$459
- Regeneron Healthcare Solutions, Inc.$227
- LEO Pharma Inc.$201
- Lilly USA, LLC$142
- Merz North America, Inc.$75
- plus $574 from 15 others
What the payments were for
- Food & beverage$2,326100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 33 | $647 |
| AbbVie(2 entities) | 22 | $459 |
| Regeneron Healthcare Solutions, Inc. | 8 | $227 |
| LEO Pharma Inc. | 9 | $201 |
| Lilly USA, LLC | 9 | $142 |
| Merz North America, Inc. | 1 | $75 |
| Sanofi | 3 | $74 |
| Johnson & Johnson | 3 | $74 |
| Galderma Laboratories, L.p. | 3 | $68 |
| E.r. Squibb & Sons, L.L.C. | 2 | $59 |
| Incyte Corporation | 2 | $49 |
| Sun Pharmaceutical Industries Inc. | 2 | $43 |
| Pfizer | 2 | $42 |
| Almirall LLC | 2 | $37 |
| Prugen, Inc. Pharmaceuticals | 4 | $25 |
| Bristol Myers Squibb | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Aclaris Therapeutics, Inc. | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $14 |
| VYNE Pharmaceuticals Inc. | 1 | $12 |
How this compares
$2,326 in reported general payments places this provider in the 55th percentile of 1,875 dermatology providers in California.
Other dermatology in Orange
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.